Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A209132
Product Number: 001
Approval Date: Apr 24, 2019
Applicant Holder Full Name: SOMERSET THERAPEUTICS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
